Skip to content

Author

Jian-Ping Liu

We have 2 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Comment on Ostrominski et al. Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations

We read with interest the report by Ostrominski et al. (1), which used two target-trial emulations to compare tirzepatide with dulaglutide or semaglutide among patients with type 2 diabetes and established atherosclerotic cardiovascular disease. The study is timely and carefully constructed. Our concern is not whether...

Yazhou Zhang, Jian-Ping Liu · 0 citations
Review Open access Jul 2026

Bone niche-driven antitumor immune failure in osteosarcoma: Mechanisms and therapeutic implications (Review)

An evidence-graded bone niche-driven framework of layered antitumor immune failure in OS is presented, in which the skeletal niche is not treated as a passive anatomical background but as a spatial and temporal organizer of immune-cell trafficking, myeloid remodeling, treatment-induced repair programs, systemic niche c...

Bolin Tang, Yu-Huai Wu, Jian-Ping Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.